Featured Firms
Presented by BigVoodoo
Antitrust regulators cleared the way on Friday for Amgen Inc.'s purchase of Immunex Corp., the biggest biotechnology merger ever. The Federal Trade Commission proposed an order that would allay antitrust concerns by making Immunex sell its cancer-fighting drug Leukine to Schering AG. Amgen and Immunex currently compete in the billion-dollar market for drugs that regenerate white blood cells.
July 16, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS